Patents by Inventor Michel Chartrain

Michel Chartrain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8603798
    Abstract: The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of E. coli, including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: December 10, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michel Chartrain, Laura Kizer Bentley, Barbara Ann Krulewicz, Kristin M. Listner, Wen-jun Sun, Chanyong Brian Lee
  • Publication number: 20120190073
    Abstract: The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of E. coli, including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
    Type: Application
    Filed: July 25, 2011
    Publication date: July 26, 2012
    Inventors: Michel CHARTRAIN, Laura Kizer BENTLEY, Barbara Ann KRULEWICZ, Kristin M. LISTNER, Wen-jun SUN, Chanyong Brian LEE
  • Patent number: 7998732
    Abstract: The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of E. coli, including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: August 16, 2011
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michel Chartrain, Laura Kizer Bentley, Barbara Ann Krulewicz, Kristin M. Listner, Wen-jun Sun, Chanyong Brian Lee
  • Publication number: 20080274452
    Abstract: The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of E. coli, including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
    Type: Application
    Filed: January 31, 2005
    Publication date: November 6, 2008
    Inventors: Michel Chartrain, Laura Kizer Bentley, Barbara Ann Krulewicz, Kristin M. Listner, Wen-jun Sun, Chanyong Brian Lee
  • Patent number: 7107801
    Abstract: An anti-theft locking device for vehicles includes an annular locking sleeve mounted concentrically about and normally in frictional engagement with the vehicle steering shaft. The locking sleeve includes a body portion having a serpentine cross-sectional configuration, thereby defining on the inner periphery of the sleeve a plurality of alternate smooth convex projections and concave valleys. The convex projections are in frictional engagement with the circumferential surface of the steering shaft by a predetermined frictional force that is greater than the rotational torque force produced during normal steering operation of the vehicle. A plurality of circumferentially spaced teeth extend radially outwardly from the locking sleeve, thereby to define between the teeth a plurality of locking slots one of which is arranged to receive the free extremity of the locking arm of a locking device.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 19, 2006
    Assignee: Nacam France S.A.
    Inventors: Michel Chartrain, Arnaud Janvier
  • Publication number: 20050092044
    Abstract: An anti-theft locking device for vehicles includes an annular locking sleeve mounted concentrically about and normally in frictional engagement with the vehicle steering shaft. The locking sleeve includes a body portion having a serpentine cross-sectional configuration, thereby defining on the inner periphery of the sleeve a plurality of alternate smooth convex projections and concave valleys. The convex projections are in frictional engagement with the circumferential surface of the steering shaft by a predetermined frictional force that is greater than the rotational torque force produced during normal steering operation of the vehicle. A plurality of circumferentially spaced teeth extend radially outwardly from the locking sleeve, thereby to define between the teeth a plurality of locking slots one of which is arranged to receive the free extremity of the locking arm of a locking device.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 5, 2005
    Inventors: Michel Chartrain, Arnaud Janvier
  • Patent number: 6207444
    Abstract: This invention relates to crystalline pharmaceutically acceptable salts of an alpha 1a adrenergic receptor antagonist, Compound A, which are useful in the treatment of benign prostatic hyperplasia. Pharmaceutical compositions employing the crystalline salts, and processes for making and using the crystalline salts and pharmaceutical compositions of Compound A are also disclosed. This invention further relates to a process for obtaining enantiomerically pure intermediate useful for the synthesis of end product alpha 1a adrenergic receptor antagonists. The end product compounds are useful for the treatment of benign prostatic hyperplasia and for relaxing lower urinary tract tissue. The invention also relates to a process for preparing a class of dihydropyrimidinone compounds of which Compound A is a member, wherein the process involves deprotonating a dihydropyrimidinone compound and then coupling the deprotonated derivative with a primary amine.
    Type: Grant
    Filed: July 24, 1998
    Date of Patent: March 27, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Daniel R. Sidler, Michel Chartrain, Norihiro Ikemoto, Gerald F. Bills, Christopher Roberge, Colleen S. Taylor
  • Patent number: 6092955
    Abstract: In a device for holding a first member in position relative to a second member, the first member and the second member are connected by a clamping system having a clamping axle passing through the members. A relatively soft plastics material adhesion shoe is fixed to the second member. The clamping axle passes through the adhesion shoe. A metal rack having teeth is disposed on a base which is mounted on the clamping axle. When the clamping system is immobilized in a locked position, the teeth of the rack penetrate the relatively soft plastics material of the adhesion shoe in order to guarantee that the first member is held in position relative to the second member.
    Type: Grant
    Filed: June 15, 1998
    Date of Patent: July 25, 2000
    Assignee: Lemforder Nacam SA
    Inventors: Michel Chartrain, Laurent Gallou
  • Patent number: 5958743
    Abstract: A bioconversion process where benzyl acetoacetate is converted to benzyl-(S)-(+)-3-hydroxybutyrate.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: September 28, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Michel Chartrain, James M. McNamara
  • Patent number: 5929243
    Abstract: The present invention is concerned with a novel process for the preparation of a compound of the formula: ##STR1## This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity.
    Type: Grant
    Filed: April 2, 1998
    Date of Patent: July 27, 1999
    Assignee: Merck & Co., Inc.
    Inventors: David Askin, Peter Maligres, Michel Chartrain, Ralph Volante
  • Patent number: 5894753
    Abstract: In a method of producing splines on a shaft, cold deformation without removal of chips is effected on the outside face of a small-thickness tube in a single operation. The cold deformation includes hammering the small-thickness tube by a conjugate and simultaneous action of beating and kneading. The depth of the splines can be as much as half the thickness of the tube.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: April 20, 1999
    Assignee: Lemforder Nacam
    Inventors: Christophe Sachot, Andre Laisement, Michel Chartrain
  • Patent number: 5871981
    Abstract: A method for preparing (1S)-amino-(2R)-indandiol substantially free of its stereoisomers is presented. The method comprises culturing indene with Rhodococcus sp. ATCC 55805, recovering the indandiol and subjecting the indandiol to chiral specific crystallization, treatment with strong acid and reverse ion pair extraction.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: February 16, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Michel Chartrain, Barbara A. Jackey, Brian Heimbuch, Colleen S. Taylor
  • Patent number: 5534422
    Abstract: A biotransformation process for the production of an intermediate used in the chemical synthesis of an antibiotic compound.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: July 9, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Michel Chartrain, Joseph D. Armstrong, III